When a reader types a question into Perplexity, the response that comes back is not ten blue links. It is a paragraph, written in plain English, with footnoted citations to the web pages it drew from. That single design choice, treating a query as a question to be answered rather than a string to be matched, is the bet that has carried a three-year-old San Francisco company from a seed round to roughly $1.5 billion in total disclosed funding [Crunchbase].
A quick caveat on beat: I usually cover clinical AI, where the patient outcome is the lede and the FDA is the gatekeeper. Perplexity sits outside that world. There is no disease state here, no Phase 3 readout, no regulator standing between the product and the user. The standard of care, if we can borrow the phrase, is Google: a decade-plus of ranked links, ads above the fold, and an SEO economy built around them. That is the incumbent Perplexity is trying to displace, and the comparison matters because it sets the bar for what "working" looks like.
The bet
Perplexity AI was founded in August 2022 by Aravind Srinivas, Denis Yarats, Johnny Ho, and Andy Konwinski, a group whose backgrounds span back-end systems, machine learning, and AI research [Wikipedia]. The company launched its main search product in December of that year [Wikipedia]. The pitch to users is straightforward: combine a large language model with real-time web retrieval, then return a concise answer with in-line citations to the sources [Crunchbase] [LinkedIn]. No ads. No scroll-and-guess. The wedge is the format itself.
In 2025 the company extended that wedge into the browser, releasing Comet, an AI-native browser positioned for both consumers and enterprise users, available free worldwide [Perplexity AI]. Owning the browser is a meaningful strategic move. It is the surface where queries originate, where context lives across tabs, and where an answer engine can plausibly intercept the moment a user reaches for the address bar.
Why it could be big
The investor list reads like a who's who of people who have been right about AI infrastructure before. NVIDIA, NEA, IVP, Databricks, Elad Gil, and Nat Friedman have all backed the company [Crunchbase] [Britannica]. NVIDIA's involvement is particularly notable: the chipmaker has been selective about strategic bets in the application layer, and its presence on the cap table signals confidence that Perplexity's compute appetite is worth supplying.
Funding has scaled accordingly. A 2024 Series B brought in $165 million, and subsequent rounds reported by Tech Funding News added $100 million and $200 million in additional capital. Crunchbase News separately reported the company exploring a raise of $250 million or more at a valuation of $2.5 billion or higher [Crunchbase News]. Total disclosed funding now sits near $1.5 billion [Crunchbase].
Series B 2024 | 165 | $M
Later round (reported) | 100 | $M
Later round (reported) | 200 | $M
The market shape favors the ambition. Search is one of the largest revenue pools in software, and the format has been essentially unchanged for two decades. If a meaningful slice of users come to prefer answers over links, the upside is enormous. The credible bull case is that Perplexity becomes the default front door for the kind of research-and-summarize queries that today require opening five tabs, and that Comet turns the browser itself into a distribution moat.
The team and traction
Srinivas, the CEO, came out of OpenAI and has been the public face of the company, writing for outlets including TechCrunch [TechCrunch]. Yarats, Ho, and Konwinski round out a co-founding team with research and engineering depth across the stack [Wikipedia]. Konwinski's prior track record includes co-founding Databricks, which is also now an investor in Perplexity [Britannica]. The product launched in December 2022 and has accumulated enough usage and investor conviction in under three years to be reported as approaching or exceeding unicorn status [Crunchbase News].
Comet's worldwide free release in 2025 is the most concrete recent traction signal [Perplexity AI]. Browsers are notoriously hard to distribute. Putting one out for free, globally, suggests the company believes the strategic value of the surface area exceeds the near-term monetization it could extract by gating it.
The honest counterfactual
The sharpest question facing Perplexity is whether Google will simply absorb the format. Bears point out that Google has already rolled AI Overviews into its core search results, and that the incumbent has both the index and the distribution to match Perplexity's answer-with-citations experience without users ever changing defaults. The competitive set named in the company's own profile lists Google directly [Crunchbase]. The bull answer, and it is a real one, is that Google's ad-supported business model creates a structural conflict: every answer that fully satisfies a user is a click that does not happen on a sponsored link. Perplexity has no such conflict. That asymmetry is why a focused challenger can sometimes hold ground a larger incumbent cannot defend without cannibalizing itself, and it is the strategic logic that the company's investors appear to be underwriting.
What to watch
The next twelve months will turn on three things. First, whether Comet's global free release converts into measurable share of the browser market, or at least into a defensible base of daily active users who route their queries through Perplexity by default. Second, whether the reported $250 million-plus round materializes and at what valuation [Crunchbase News], which will set the bar for the company's revenue ramp expectations. Third, the introduction of Perplexity Computer, teased on the company's own blog [Perplexity AI], which suggests the roadmap is moving from answering questions toward executing tasks. That is a much harder product to build, and a much larger one if it works.
The disease state here, to keep the metaphor, is information overload, and the patient population is anyone who uses the internet to learn something. The standard of care has not been refreshed in a generation. Perplexity is one of the few companies with the capital, the team, and the product surface to credibly propose a new one. Whether the body accepts the transplant is the story of the next year.
Pulse Raman, Startuply